The stock's fall snapped a three-day winning streak.

Henry Schein, Inc.’s HSIC joint venture, Henry Schein One, is driving strong growth in its core products and introducing new solutions. The company’s robust acquisition strategy helps it to pursue ...

Henry Schein Inc. closed 9.71% below its 52-week high of $82.49, which the company reached on February 5th.

According to Benzinga Pro, Henry Schein's peer group average for short interest as a percentage of float is 4.30%, which means the company has more short interest than most of its peers. Did you know ...

Medical supplies distributor Henry Schein Inc on Monday missed first-quarter revenue estimates, hurt by muted demand for its dental products amid rising inflation.

MELVILLE, N.Y. (AP) — MELVILLE, N.Y. (AP) — Henry Schein Inc. (HSIC) on Monday reported first-quarter profit of $110 million. On a per-share basis, the Melville, New York-based company said it ...

Henry Schein announces executive role changesThe information in this article is based on a press release statement filed with the SEC. In other recent news, Henry Schein Inc. reported its Q4 2024 ...

Full transcript - Henry Schein Inc (HSIC) Q4 2024: Conference Operator: Good morning, ladies and gentlemen, and welcome to Henry Schein's Fourth Quarter twenty twenty four Earnings Conference Call.

Henry Schein shares up on strategic investment from KKR, management appointments, share buyback, and preliminary results.

The Acentus transaction follows Henry Schein’s acquisition of Prism Medical Products, LLC in 2021 and Shield Healthcare and Mini Pharmacy in 2023, reinforcing the Company’s strategic ...

Henry Schein has finally disclosed a data breach following at least two back-to-back cyberattacks in 2023 by the BlackCat Ransomware gang, revealing that over 160,000 people had their personal ...

During the last three months, 8 analysts shared their evaluations of Henry Schein (NASDAQ:HSIC), revealing diverse outlooks from bullish to bearish. The following table encapsulates their recent ...